Haverford Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Sell
12,795
-30
-0.2% -$30.7K 4.52% 8
2026
Q1
$11.8M Sell
12,825
-10
-0.1% -$10.1K 3.51% 13
2025
Q4
$13.8M Sell
12,835
-81
-0.6% -$77.5K 3.87% 10
2025
Q3
$9.85M Buy
12,916
+4,790
+59% +$3.56M 2.77% 16
2025
Q2
$6.33M Buy
8,126
+4,433
+120% +$3.44M 1.88% 26
2025
Q1
$3.05M Sell
3,693
-35
-0.9% -$29.1K 0.94% 30
2024
Q4
$2.88M Buy
+3,728
New +$3.09M 0.88% 30

Other funds holding LLY

Haverford Financial Services's LLY Position: Q2 2026 in Review

Haverford Financial Services reduced its Eli Lilly (LLY) stake by 0.23% in Q2 2026, selling an estimated $30.7K and leaving 12,795 shares worth $15.3M. The position accounts for 4.52% of the portfolio, ranked #8.

Haverford Financial Services first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Haverford Financial Services held 12,795 shares of Eli Lilly worth $15.3M as of Q2 2026.
  • Haverford Financial Services sold 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
  • Eli Lilly made up 4.52% of Haverford Financial Services's portfolio in Q2 2026, its #8 holding.
  • Haverford Financial Services first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Haverford Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.